GASTRIC ADENOCARCINOMA OR GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA OR ESOPHAGEAL CARCINOMA
Clinical trials for GASTRIC ADENOCARCINOMA OR GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA OR ESOPHAGEAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new GASTRIC ADENOCARCINOMA OR GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA OR ESOPHAGEAL CARCINOMA trials appear
Sign up with your email to follow new studies for GASTRIC ADENOCARCINOMA OR GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA OR ESOPHAGEAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combos aim to boost survival in Hard-to-Treat cancers
Disease control CompletedThis study tested several immunotherapy-based drug combinations in 214 people with advanced stomach, gastroesophageal junction, or esophageal cancer that could not be removed by surgery or had spread. Participants received either standard chemotherapy or chemotherapy plus the imm…
Matched conditions: GASTRIC ADENOCARCINOMA OR GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA OR ESOPHAGEAL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Could a plant-based supplement calm chemo-related diarrhea?
Symptom relief CompletedThis phase II trial tested a concentrated plant dietary supplement (made from foods like taro, rice, and carrots) in 30 people with gastrointestinal cancers who had diarrhea from chemotherapy. Participants received the supplement alongside standard anti-diarrheal treatment. The g…
Matched conditions: GASTRIC ADENOCARCINOMA OR GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA OR ESOPHAGEAL CARCINOMA
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC